Healthcare IBD - Summary & Resources
####WSO resources
[Healthcare Overview](https://www.wallstreetoasis.com/forums/healthcare…)
[Biotech Finance: From IB to VC / HF to Funded Startup (Part 1)](https://www.wallstreetoasis.com/forums/biotech-fi…)
[Biotech Finance: Valuation Methodologies And Modeling Considerations (Part 2)](https://www.wallstreetoasis.com/forums/biotech-fi…)
[Q&A: BB IBD Healthcare Analyst](https://www.wallstreetoasis.com/forums/q&a-bb-ibd…)
[Questions About Healthcare M&A](https://www.wallstreetoasis.com/forums/questions-…)
[Guide to Evaluate a Biotech Company](https://www.wallstreetoasis.com/forums/guide-to-e…)
####External resources (news and reports)
[FierceBiotech](https://www.fiercebiotech.com/)
[FiercePharma](https://www.fiercepharma.com/)
[Biospace](https://www.biospace.com/news/)
[WSJ Health](https://www.wsj.com/news/business/health-industry)
[Medscape](https://www.medscape.com/)
[Bain's Global Healthcare Private Equity and Corporate M&A reports][]
[Paul Keckley's weekly report](https://www.paulkeckley.com/the-keckley-report)
[Axios Vitals](https://www.axios.com/newsletters/axios-vitals)
Medical device industry:
[Fierce MedTech](https://www.fiercebiotech.com/medtech)
[MassDevice](https://www.massdevice.com/)
[Medical Device Manufacturers Association](https://www.medicaldevices.org/news/)
####Books
**- "The Pharmagellan Guide to Biotech Forecasting and Valuation"**
**- "Biotechnology Valuation", Karl Kleegan**: Chapter 3 is about the drug development process. You can also check Chapter 4 to learn how to build a disease model. However, read this book only if you already know valuation (DCF, comps), because the author uses quick-n-dirty or overly complex techniques that you shouldn't follow as an investment banker (he was an ER guy).
####Graphic on the industry
!PHARMA(https://www.wallstreetoasis.com/files/styles/w800…)
####Bonus videos
*How To Analyze a Clinical Trial:* not directly related to IB, but still interesting in order to understand how clinical trials work and the effect of their results on share price
[Part 1](
[Part 2](https://www.youtube.com/watch?v=A-hYVtCA06c)
[Part 3]()
[Part 4](https://www.youtube.com/watch?v=_aO5BhyEgXo)
Anything I should add?
**Thanks to TheFlyingKiwi(https://www.wallstreetoasis.com/user/423544)!**
[Bain's Global Healthcare Private Equity and Corporate M&A reports]: https://www.bain.com/insights/topics/global-healt…
[Medscape]: https://www.medscape.com/
Solid thread. +1 and following.
I'd add https://www.paulkeckley.com/the-keckley-report</a">Paul Keckley's weekly report to the ex resources. He does great political analysis and provides insight from government and survey data.
https://www.medscape.com/</a">Medscape
https://www.fiercebiotech.com/medtech</a">Fierce MedTech
https://www.massdevice.com/</a">Mass Device
WSJ Health
https://www.medicaldevices.org/news/</a">Med Dev Manufacturers Assoc (I just follow the Twitter account)
WSO:
https://www.wallstreetoasis.com/forums/biotech-finance-part-2-valuation…</a">Biotech Finance Part 2: Valuation Methodologies And Modeling Considerations
https://www.wallstreetoasis.com/forums/guide-to-evaluate-a-biotech-comp…</a">Guide To Evaluate A Biotech Company
Nice graphic on the industry.
Can't think of anymore off the top of my head. Looking forward to what others say as well.
I'm adding your links, thanks!
Cheers! Would be interested if other users follow any individual Twitter accounts that posts good insights/knowledge. Always hard to find those.
bump
bump
bump
bump
Bump
Bump
Bump
Bump
Bump
https://www.mobihealthnews.com/
I work in HCIT corporate right now and read a lot from this website as well as CB Insights Digital Health (very solid). Pretty sure HW or HL has a public report about HCIT companies in 2020 (fairly in depth, similar to CB Insights).
Associate exit opps?
bump
Bump
wondering if anyone has any good healthcare business books?
Bump
B
B
Sit et id cumque. Ab quam vel necessitatibus magni ullam.
Ut vel in molestias eum perferendis. Nostrum ea corporis et inventore fugit sed rem quia. Ipsa praesentium rem porro quos. Inventore quia dolor quaerat sint aperiam error. In omnis recusandae perferendis. Voluptatum non consequatur quia molestiae rerum.
Non unde pariatur magni neque quos minus. Vel est eveniet neque alias et. Architecto ad libero eos consequatur aut sed non. Doloribus id veniam repellat rem. Quia perferendis eos dolorem.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...
Autem et debitis dolorem ad. Officia minima vel necessitatibus cupiditate minus praesentium aut. Modi nam et nostrum aperiam enim repudiandae.
Vitae soluta odit qui placeat dolores omnis. Saepe nesciunt voluptate veritatis itaque natus quo ratione. Maiores adipisci aut velit quos dolore. Et nihil recusandae eum. Eos sunt minus velit quo voluptates. Est sapiente iure aspernatur aliquam id et qui.